NASDAQ · SIGA
Healthcare · Drug Manufacturers - Specialty & Generic
$3.04
Up+$0.07 (+2.36%)
Updated Aug 22, 2026, 12:27 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
SIGA closed at $3.04 after 21 trading sessions, down 2.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.99 | $3.09 | $2.95 | $3.04 | 1.54M |
| Aug 20, 2026 | $3.10 | $3.10 | $2.93 | $2.97 | 582.59K |
| Aug 19, 2026 | $2.99 | $3.12 | $2.97 | $3.11 | 898.45K |
| Aug 18, 2026 | $2.92 | $3.00 | $2.88 | $2.99 | 457.04K |
| Aug 17, 2026 | $3.00 | $3.00 | $2.8811 | $2.93 | 766.76K |
| Aug 14, 2026 | $2.89 | $3.01 | $2.855 | $3.00 | 588.16K |
| Aug 13, 2026 | $2.89 | $2.94 | $2.855 | $2.88 | 479.91K |
| Aug 12, 2026 | $2.87 | $2.92 | $2.83 | $2.87 | 636.6K |
| Aug 11, 2026 | $2.93 | $2.99 | $2.87 | $2.88 | 582.33K |
| Aug 10, 2026 | $3.07 | $3.081 | $2.86 | $2.93 | 1.02M |
| Aug 7, 2026 | $3.15 | $3.19 | $3.035 | $3.05 | 678.83K |
| Aug 6, 2026 | $3.15 | $3.195 | $3.10 | $3.12 | 493.55K |
| Aug 5, 2026 | $3.24 | $3.24 | $3.11 | $3.15 | 418.1K |
| Aug 4, 2026 | $3.20 | $3.29 | $3.19 | $3.24 | 468.24K |
| Aug 3, 2026 | $3.31 | $3.31 | $3.175 | $3.21 | 515.54K |
| Jul 31, 2026 | $3.25 | $3.32 | $3.15 | $3.27 | 661.03K |
| Jul 30, 2026 | $3.33 | $3.33 | $3.21 | $3.25 | 431.7K |
| Jul 29, 2026 | $3.33 | $3.43 | $3.29 | $3.34 | 1.01M |
| Jul 28, 2026 | $3.11 | $3.34 | $3.01 | $3.34 | 1.18M |
| Jul 27, 2026 | $3.13 | $3.21 | $3.02 | $3.10 | 3.97M |
| Jul 24, 2026 | $3.14 | $3.175 | $3.03 | $3.11 | 877.47K |
The latest Smart Investors Daily articles mentioning SIGA.
SIGA research
Company profile and research snapshot.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Aug 7, 2026
https://www.cdc.gov/measles/data-research/index.html
SeekingAlpha · Aug 7, 2026
SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsDiem Nguyen - CEO & DirectorDaniel Luckshire -...
Benzinga · Aug 6, 2026
SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.17 per share. This is a 65.31 percent decrease over earnings of $0.49 per share from the same period last year. The company reported $41.002 million in
SeekingAlpha · Jul 28, 2026
SIGA Technologies, Inc. stays Hold as BARDA renewal drives revenue visibility; TPOXX headwinds persist. Click for this SIG stock update.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SIGA.
